Edward H. Stratemeier
Direktor/Vorstandsmitglied bei Igxbio, Inc.
Profil
Edward H.
Stratemeier is currently a Director at Igxbio, Inc. He previously worked as Secretary, SVP-Legal Affairs & General Counsel at NPS Pharmaceuticals, Inc. from 2011 to 2014 and as Senior Vice President-Legal & Government Relations at Aventis Pharmaceuticals, Inc. He holds an MBA from Rockhurst University, an undergraduate degree from the University of Kansas, and a graduate degree from the University of Missouri-Kansas City.
Aktive Positionen von Edward H. Stratemeier
Unternehmen | Position | Beginn |
---|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Direktor/Vorstandsmitglied | 30.03.2009 |
Ehemalige bekannte Positionen von Edward H. Stratemeier
Unternehmen | Position | Ende |
---|---|---|
NPS PHARMACEUTICALS, INC. | General Counsel | 28.02.2014 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | General Counsel | - |
Ausbildung von Edward H. Stratemeier
University of Missouri-Kansas City | Graduate Degree |
Rockhurst University | Masters Business Admin |
University of Kansas | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |